ArticleScientific reports2024

A Bruton tyrosine kinase inhibitor-resistance gene signature predicts prognosis and identifies TRIP13 as a potential therapeutic target in diffuse large B-cell lymphoma.

Yangyang Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.